Quadlytics Inc. has raised $3.8M in Series B funding to advance its AI-powered approach to epilepsy care. The company is building technology aimed at one of the field's hardest problems: seizure unpredictability.
Its platform pairs wearable sensing with machine learning to detect anomalous physiological changes in wearable data, then surfaces timely insights for patients and caregivers while giving clinicians relevant data for care discussions. The goal is earlier preparation and more informed decision-making - a shift toward proactive epilepsy care. The technology is still under development and not yet available for clinical use.
